Related Experiment Video
Updated: Apr 3, 2026

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
Electroacupuncture alleviates cisplatin-induced nausea in rats
Yingxue Cui1, Linpeng Wang1, Guangxia Shi1
1Acupuncture and Moxibustion Department, Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University, Beijing, China.
Electroacupuncture (EA) effectively treats chemotherapy-induced nausea and vomiting in rats by reducing serotonin and nucleus of the solitary tract activity. This study elucidates EA's anti-emetic mechanisms, offering potential therapeutic insights.
Area of Science:
- Neuroscience
- Gastroenterology
- Integrative Medicine
Background:
- Chemotherapy often causes nausea and vomiting, significantly impacting patient quality of life.
- Acupuncture, particularly electroacupuncture (EA), shows promise in managing these side effects.
- The precise mechanisms underlying EA's anti-emetic effects require further investigation.
Purpose of the Study:
- To explore the underlying mechanisms of electroacupuncture's (EA) anti-emetic effects in a rat model of chemotherapy-induced nausea and vomiting (CINV).
Main Methods:
- A rat model of CINV was established using cisplatin administration.
- EA was applied at specific acupoints (CV12, PC6) or sham points.
- Nausea and vomiting severity were assessed via kaolin intake, food intake, and body weight changes.
- Serotonin (5-HT) levels in the duodenum and c-Fos expression in the nucleus of the solitary tract (NTS) were quantified.
Main Results:
- EA at the CV12 acupoint significantly reversed cisplatin-induced nausea and vomiting markers.
- EA at CV12 attenuated elevated duodenal serotonin (5-HT) and suppressed c-Fos expression in the NTS.
- EA at the PC6 acupoint showed limited effects on nausea/vomiting and physiological markers.
Conclusions:
- Electroacupuncture demonstrates significant anti-emetic effects in a rat model of CINV.
- The anti-emetic action of EA is likely mediated by inhibiting duodenal serotonin release and modulating NTS activity.
- Findings suggest EA as a potential therapeutic strategy for managing chemotherapy-induced nausea and vomiting.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
